GeneDx shares sink as Q1 results prompt sharp cut to 2026 revenue outlook

GeneDx Holdings Corp. (WGS) is down 47.7% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to GeneDx’s first-quarter 2026 earnings update, where the company reduced its full-year 2026 revenue outlook and guided to a softer second quarter. Even though exome and genome testing volumes grew strongly year over year, the reset in near-term expectations likely drove investors to reprice the shares quickly.

Details:

GeneDx reported first-quarter 2026 revenue of $102.3 million (up 17% year over year) and noted 27% growth in exome and genome test revenue.

Exome and genome test result volume was 27,488 in Q1, up 34% year over year, while adjusted gross margin was 69% (GAAP gross margin 67%).

The company updated full-year 2026 revenue guidance to $475 million to $490 million, down from prior guidance of $540 million to $555 million.

Second-quarter 2026 revenue guidance was set at $110 million to $112 million, and the company’s Q2 outlook also included an adjusted net loss expectation of about $5 million.

Sources:

SEC (EDGAR), GeneDx Investor Relations, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$WGS Insider Trading Activity

$WGS insiders have traded $WGS stock on the open market 91 times in the past 6 months. Of those trades, 10 have been purchases and 81 have been sales.

Here’s a breakdown of recent trading of $WGS stock by insiders over the last 6 months:

KEITH A. MEISTER has made 10 purchases buying 169,521 shares for an estimated $13,460,089 and 0 sales.
KATHERINE STUELAND (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 26 sales selling 107,892 shares for an estimated $8,724,277.
JOSHUA RUCH has made 0 purchases and 15 sales selling 38,000 shares for an estimated $6,093,967.
KEVIN FEELEY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 28 sales selling 27,205 shares for an estimated $2,376,762.
BRYAN DECHAIRO (Chief Operating Officer) has made 0 purchases and 12 sales selling 9,374 shares for an estimated $850,555.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$WGS Hedge Fund Activity

We have seen 132 institutional investors add shares of $WGS stock to their portfolio, and 156 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 581,515 shares (-81.0%) from their portfolio in Q4 2025, for an estimated $75,631,840
WESTFIELD CAPITAL MANAGEMENT CO LP added 474,167 shares (+87.1%) to their portfolio in Q4 2025, for an estimated $61,670,160
FRANKLIN RESOURCES INC added 411,607 shares (+60.4%) to their portfolio in Q4 2025, for an estimated $53,533,606
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 410,928 shares (-33.7%) from their portfolio in Q4 2025, for an estimated $53,445,295
PENTWATER CAPITAL MANAGEMENT LP removed 375,000 shares (-88.2%) from their portfolio in Q4 2025, for an estimated $48,772,500
FMR LLC added 329,429 shares (+65.5%) to their portfolio in Q4 2025, for an estimated $42,845,535
JENNISON ASSOCIATES LLC removed 296,277 shares (-49.5%) from their portfolio in Q4 2025, for an estimated $38,533,786

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$WGS Analyst Ratings

Wall Street analysts have issued reports on $WGS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Canaccord Genuity issued a "Buy" rating on 12/22/2025

To track analyst ratings and price targets for $WGS, check out Quiver Quantitative's $WGS forecast page.

$WGS Price Targets

Multiple analysts have issued price targets for $WGS recently. We have seen 5 analysts offer price targets for $WGS in the last 6 months, with a median target of $90.0.

Here are some recent targets:

Mark Massaro from BTIG set a target price of $90.0 on 05/05/2026
Brandon Couillard from Wells Fargo set a target price of $75.0 on 05/05/2026
Subbu Nambi from Guggenheim set a target price of $70.0 on 05/05/2026
Kyle Mikson from Canaccord Genuity set a target price of $100.0 on 04/20/2026
David Westenberg from Piper Sandler set a target price of $130.0 on 02/24/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.